|
| |
| |
|
 |
Boehringer Ingelheim Chooses IDBS'
PredictionBase
|
Guildford, United Kingdom, April 11th 2008 - IDBS, a provider of drug
discovery data management solutions, today announced that the global
pharmaceutical company Boehringer Ingelheim (Ingelheim, Germany) has purchased
IDBS’ predictive modelling technology PredictionBase for use at its Biberach an
der Riss research site.
Scientists at the Biberach facility, where research into diseases of the central
nervous system (CNS), metabolic diseases and respiratory diseases is centred,
will use PredictionBase to build and deploy and distribute predictive ADME QSAR
models using existing data.
Boehringer Ingelheim sought a solution that would help reduce the effort
required for scientists to perform prediction manually, while also efficiently
distributing valuable drug discovery knowledge throughout the company.
PredictionBase provided the required predictive technology to integrate with
existing Boehringer Ingelheim IT tools to form an automated workflow, allowing
scientists to save time by prioritizing work, so improving efficiency.
Neil Kipling, founder and CEO of IDBS, commented: "Increasingly, organizations
are opting for predictive technologies that help reduce costs incurred by failed
candidates by weeding out potential failures before screening begins. Boehringer
Ingelheim sought to increase efficiency of the candidate identification process
by introducing an automated workflow. Use of PredictionBase has helped its
scientists streamline working practises when dealing with larger volumes of
data.” He added: “By providing scientists with a tool to create, analyze and
validate predictive models, PredictionBase enables the easy generation and
distribution of knowledge across organizations.”
About IDBS:
IDBS is a leading provider of integrated software solutions to the life sciences
industry. Maximising the value of research data by enabling organisations to
capture, store, share and use data efficiently and effectively, whilst
protecting intellectual property across the spectrum of discovery activities.
Headquartered in Guildford, UK, IDBS has U.S. offices in California, New Jersey
and Massachusetts. IDBS partners with CTC Laboratory Systems in Japan and a
network of distributors to market IDBS products and services in Asia. Founded in
1989, IDBS employs more than 150 people worldwide.
Product enquiries
IDBS:
Glyn Williams, VP of Marketing & Product Management:
Tel: +44 (0)1483 595010 Email:
gwilliams@idbs.com
Media enquiries
Alto Marketing Limited:
Nicki Muir
Tel: +44 (0)1489 557672 Email:
nickim@alto-marketing.com
| |
|